Project Details
Description
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects with Nonsense-Mutation-Mediated Duchenne and Becker Muscular Dystrophy
| Status | Finished |
|---|---|
| Effective start/end date | 3/1/08 → 2/28/12 |
Funding
- PTC THERAPEUTICS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.